T-cell-immunity-based inhibitory effects of orally administered herbal medicine Juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice

Journal of Investigative Dermatology

Volumn 117, Issue 3, 2001, Pages 694-701

  Dai, Y ^a   Kato, M ^a   Takeda, K ^a   Kawamoto, Y ^a   Akhand, A A ^a   Hossain, K ^a   Suzuki, H ^a   Nakashima, I ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antitumor immunity; Glycirrhizin; Malignant melanoma

Indexed keywords

GINSENOSIDE RB 1; GLYCYRRHIZIC ACID; LIQUIRITIN; PAEONIFLORIN; SHI QUAN DA BU TANG; THY 1 ANTIGEN; XIAO CHAI HU TANG;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL DEATH; CELL GROWTH; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DNA SYNTHESIS; DRUG EFFECT; LIFESPAN; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; TUMOR GROWTH;

EID: 0034791135     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01457.x     Document Type: Article

References (34)

1. Spontaneous melanocytosis in transgenic mice
2. Recombinant ret oncogene product induced T lymphocyte proliferation which suppressed lymphoma derived from ret transgenic mice
3. Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1)
4. Record low global ozone in 1992
5. Effect of a kampo medicine zyuzentaihoto on the immune reactivity of tumor-bearing mice
6. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs
7. Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in Eu/ret transgenic mice
8. Juzen-taiho-to, a Japanese herbal medicine, modulates type-1 and type-2 T cell responses in old BALB/c mice
9. Characterization of the immuno-regulatory ation of salkosaponin-d
10. Cell type-oriented differential modulatory actions of salkosaponin-d on growth response and DNA fragmentation of lymphocytes triggered by receptor-mediated and receptor-bypassed pathways
11. The herbal medicine sho-salko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice
12. Transgenic mouse model for skin malignant melanoma
13. Linkage between melanocytic tumor development and early burst of RET protein expression for tolerance induction in metallothioncin-I/ret transgenic mouse lines
14. Further characterization of the sho-saiko-to-mediated anti-tumor effect on melanoma developed in RET-transgenic mice
15. Characterization of mitogenic pectic polysaccharides from kampo (Japanese herbal) medicine Juzen-taiho-to
16. Characterization of in vitro IL-2-production-enhancing and anticomplementary pectic polysaccharides from Kampo (Japanese herbal) medicine Juzen-taiho-to
17. The herbal medicine Sho-salko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting the cell cycle through downregulation of cycline-dependent kinases
18. Antitumor effect of Juzen-taiho-to, a kampo medicine, combined with surgical excision of transplanted Meth-A fibrosarcoma
19. Orally administered kampo (Japanese herbal) medicine Juzen-taiho-to modulates cytokine secretion in gut associated lymphoreticular tissues in mice
20. Orally administered decoction of kampo (Japanese herbal) medicine Juzen-taiho-to modulates cytokine secretion and induces NKT cells in mouse liver
21. Development of high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (k7L) that induces temporal growth of L1210 leukemia-K7L-variant
22. Control of primary IgM antibody responses to H-2 alloantigens by antigen-bearing live B lymphocytes
23. Evidence of synergy between Thy-1 and CD3/TCR complex in signal delivery to murine thymocytes for cell death
24. Effects of Juzen-talho-to (TAS), a traditional oriental medicine, on hematopoictic recovery from radiation injury in mice
25. Inhibitory effect of traditional Chinese medicine Juzentailio-to on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma
26. HPLC analysis Juzen-taiho-to and its variant formulations and their antimetastatic efficacies
27. Improvement of cisplatin toxicity and lethality by Juzen-taiho-to in mice
28. Protective effect of Juzen-taiho-to against carboplatininduced toxic side effects in mice
29. Establishment and characterization of a malignant malanocytic tumor cell line expressing the ret oncogene
30. Enhancement of nitric oxide production from activated macrophages by glycyrrhizin
31. Modulation by glycyrrhizin of the cell surface expression of H-2 class 1 antigens on murine tumor cell lines and normal cell populations
32. Bidirectional control by glyeyrrhizin of the growth response of lymphocytes stimulated through a receptor-bypassed pathway
33. Glycyrrhizin as promoter of the late signal transduction by splenic lymphocytes
34. Dissociated control by glycyrrhizin of proliferation and IL-2 production of murine thymocytes